Purchase Order 75N93018P00045
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the procurement of an EXPIFECTAMINE 293 Transfection Kit. The contract has a ceiling value of $14,825.60 and a completion date of July 7, 2015. The contract was awarded on June 24, 2015 and did not utilize any set-aside designations. As a...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the procurement of ExpiFectamine transfection kits and OptiMEM media, which are used in the production of recombinant proteins and monoclonal antibodies for NIAID's Vaccine Research Center. The total ceiling value of the contract is...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for EXPIFECTAMINE Transfection Reagent Kits. The $56,950.00 contract has a completion date of June 30, 2023 and does not utilize any set-aside designations. The original solicitation was issued as a simplified acquisition for commercial items under FAR Part 13. Life Technologies Corporation, as a...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $19,380.00 firm fixed price purchase order is for EXPI293 Expression Medium and ExpiFectamine 293 Transfection Kit products, which support biomedical research. Life Technologies is a division of the parent company...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $51,260.80, is for the procurement of 8 units of the ExpiFectamine 293 Transfection Kit, a 10-liter product, to be used by NIAID's Vaccine Research Center in its efforts to develop...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the procurement of 5 Expifectamine Transfxn Reagent Kits, with a ceiling value of $23,643.00. The contract has an ultimate completion date of August 20, 2021 and was awarded on July 20, 2021. No set-aside was used...
- This federal contract award, with a ceiling value of $6,620.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the procurement of the EXPIFECTAMINE 293 TRANSFECTION KIT CAT#A14524, which is used in biomedical research and genetic analysis. The contract is a firm fixed-price purchase order awarded on October 30, 2014, with a completion date of November 29, 2014....
- This is a $6,620 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the supply of an EXPIFECTAMINE 293 Transfection Kit, a specialized reagent used in biomedical research and genetic analysis. The award does not involve any set-aside designations. Life Technologies...
- This contract award involves the purchase of 20 units of the Expifectamine Transfection Reagent Kit 10L (Cat# A14525) from Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract, with a ceiling value of $54,600.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) on May 14, 2015, with a completion date of May 13, 2016. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Life Technologies...
- This is a $24,570.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is a Blanket Purchase Agreement (BPA) call order for the Expifectamine transfection kit, a reagent used for genetic engineering and cell culture applications. As the prime contractor, Life Technologies is responsible for providing the...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the procurement of Expifectamine Transfection Kit and EXPI293 Expression Medium. The contract has a ceiling value of $95,780.00 and a period of performance from October 1, 2018 to September 30, 2019. This order was competed on the open market and did not utilize any set-aside designations. Life Technologies has a history of serving as a prime contractor for NIAID, DoD, USDA, and other federal agencies, providing a range of biotechnology products and services to support biomedical research, medical readiness, and other government initiatives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Expifectamine Tranfxn Kit and EXPI293 Expression Medium | NIAID-RFQ18-1918640 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 9/19/18, 8:09 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.8k | 9/26/18 |